Top Banner

Click here to load reader

D.Rizik, tryton breakfast symposium_real world applications

Apr 14, 2017

ReportDownload

Healthcare

  • Scot

    tsda

    le-L

    inco

    ln H

    ealth

    Net

    wor

    k

    Tryton Breakfast Symposium:Real World Applications

    David G. Rizik, M.D., F.A.C.C., F.S.C.A.I.Chief Scientific Officer

    Director of Structural & Coronary InterventionsHonorHealth and the Scottsdale-Lincoln

    HealthNetworkHon

    orH

    ealth

    / Sco

    ttsd

    ale-

    Lin

    coln

    Hea

    lth N

    etw

    ork

  • Scot

    tsda

    le-L

    inco

    ln H

    ealth

    Net

    wor

    k

    Disclosure Statement

    Abbott Vascular: Medical Advisory Board, Research & Education Support.

    Boston Scientific: Executive Physician Council, Research & Education Support

  • Scot

    tsda

    le-L

    inco

    ln H

    ealth

    Net

    wor

    kTryton Side Branch StentSave the Side Branch Strategy

    Open strut architecture

  • Scot

    tsda

    le-L

    inco

    ln H

    ealth

    Net

    wor

    kPhantom Model Deployment

    Tryton Side Branch Stent

  • Scot

    tsda

    le-L

    inco

    ln H

    ealth

    Net

    wor

    k

    Tryton Deployment Sequence1. Wire both vessels and pre-dilate SB 2. Position Tryton

    3. Perform P.O.T. 4. Position DES and remove jailed wire

    5. Deploy DES and re-wire SB 6. Simultaneous Kissing Balloon

  • Scot

    tsda

    le-L

    inco

    ln H

    ealth

    Net

    wor

    k

    Tryton Case

  • Scot

    tsda

    le-L

    inco

    ln H

    ealth

    Net

    wor

    k

  • Scot

    tsda

    le-L

    inco

    ln H

    ealth

    Net

    wor

    k

  • Scot

    tsda

    le-L

    inco

    ln H

    ealth

    Net

    wor

    k

  • Scot

    tsda

    le-L

    inco

    ln H

    ealth

    Net

    wor

    k

    Dedicated SB Stent: ? Value

    Value: Bringing the predictability & durability seen in straight lesions to bifurcation lesions

  • Scot

    tsda

    le-L

    inco

    ln H

    ealth

    Net

    wor

    k

    Provisional (n= 143)

    Tryton (n= 146)

    Dedicated Stent: PredictabilityNear elimination of bailout stenting

    Gnreux et al. Catheter Cardiovasc Interv. 2015

    Tryton IDE Trial Intended Population

  • Scot

    tsda

    le-L

    inco

    ln H

    ealth

    Net

    wor

    kWhich Lesion? Significant Side Branch

    Side Branch Size: Significant Angle: Narrow and Wide Step-up: Large and Small

  • Scot

    tsda

    le-L

    inco

    ln H

    ealth

    Net

    wor

    k

    Which Lesion? Significant

    Significant Appropriate for a 2.5 mm diameter stent >2.25 mm by visual estimate

  • Scot

    tsda

    le-L

    inco

    ln H

    ealth

    Net

    wor

    k

  • Scot

    tsda

    le-L

    inco

    ln H

    ealth

    Net

    wor

    k

    Angle: Wide Angle: Narrow

    Which Lesion? Angle

  • Scot

    tsda

    le-L

    inco

    ln H

    ealth

    Net

    wor

    k

    SB-MB Step-up: Large SB-MB Step-up: Small

    Which Lesion? SB-MB Step-up

  • Scot

    tsda

    le-L

    inco

    ln H

    ealth

    Net

    wor

    k

    Conclusion

    When a dedicated SB Stent?Bifurcation lesions with important Side Branches

    Procedural Predictability Long term Durability